Shopping Cart
- Remove All
Your shopping cart is currently empty
BM-531 is a thromboxane A2 receptor (TXA2R) antagonist (IC₅₀ = 7.8 nM) and thromboxane synthase inhibitor exhibiting antiplatelet activity. It inhibits arachidonic acid-induced platelet aggregation and suppresses the second wave of ADP-induced aggregation.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $195 | In Stock | |
| 5 mg | $483 | In Stock | |
| 10 mg | $691 | In Stock | |
| 25 mg | $1,080 | In Stock | |
| 50 mg | $1,490 | In Stock |
| Description | BM-531 is a thromboxane A2 receptor (TXA2R) antagonist (IC₅₀ = 7.8 nM) and thromboxane synthase inhibitor exhibiting antiplatelet activity. It inhibits arachidonic acid-induced platelet aggregation and suppresses the second wave of ADP-induced aggregation. |
| Targets&IC50 | TXA2:7.8 nM |
| In vitro | BM-531 (0.0001-10 μM) exhibits high affinity for the thromboxane A₂ (TXA₂) receptor in homo sapiens platelets (IC₅₀ = 0.0078 μM, determined by competitive displacement of [³H]SQ-29548) [1]. BM-531 demonstrates anti-aggregatory effects in homo sapiens platelet-rich plasma (PRP), inhibiting arachidonic acid-induced platelet aggregation (ED₁₀₀ = 0.125 μM) and U-46619-induced platelet aggregation (ED₅₀ = 0.482 μM) [1]. BM-531 (10 μM) inhibits high K⁺-induced contraction in porcine uterine smooth muscle after 1 hour of treatment [2]. |
| Synonyms | BM531, BM 531 |
| Molecular Weight | 398.48 |
| Formula | C17H26N4O5S |
| Cas No. | 284464-46-6 |
| Color | Yellow |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.